A new study reveals for the first time that a common species of seaweed, Laminaria ochroleuca, is a rich source of bacteria with antimicrobial and anticancer activities — and potential new drug candidates.
A new study reveals for the first time that a common species of seaweed, Laminaria ochroleuca, is a rich source of bacteria with antimicrobial and anticancer activities — and potential new drug candidates.